Protein kinase C μ is down-regulated in androgen-independent prostate cancer

Biochemical and Biophysical Research Communications

Volumn 307, Issue 2, 2003, Pages 254-260

  Jaggi, Meena ^a   Rao, Prema S ^a   Smith, David J ^a   Hemstreet, George P ^a   Balaji, K C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Androgen independence; C4 2 cells; LNCaP cells; PKC ; Prostate cancer

Indexed keywords

ANDROGEN; PROTEIN KINASE C; PROTEIN KINASE C MU; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS;

EID: 0038690400     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01161-6     Document Type: Article

References (31)

1. Storz P., Hausser A., Link G., Dedio J., Ghebrehiwet B., Pfizenmaier K., Johannes F.J. J. Biol. Chem. 275:2000;24601-24607.
2. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. J. Biol. Chem. 272:1997;952-960.
3. Eisenberger M.A., Reyno L.M. Cancer Treat. Rev. 20:1994;259-273.
4. F.J. Johannes, J. Prestle, S. Eis, P. Oberhagemann, K. Pfizenmaier, J. Biol. Chem. 269 (1994) 6140-6148.
5. Powell C.T., Brittis N.J., Stec D., Hug H., Heston W.D., Fair W.R. Cell Growth Differ. 7:1996;419-428.
6. Waldron R.T., Rozengurt E. J. Biol. Chem. 278:2003;154-163.
7. Hellerstedt B.A., Pienta K.J. CA Cancer J. Clin. 52:2002;154-179.
8. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. CA Cancer J. Clin. 53:2003;5-26.
9. Grossmann M.E., Huang H., Tindall D.J. J. Natl. Cancer Inst. 93:2001;1687-1697.
10. Henttu P., Vihko P. Biochem. Biophys. Res. Commun. 244:1998;167-171.
11. Bowden E.T., Barth M., Thomas D., Glazer R.I., Mueller S.C. Oncogene. 18:1999;4440-4449.
12. M. Eisenberger, in: P.C., Walsh, A.B. Retik, D.E. Vaughan, A.J. Wein (Eds.), Campbells Urology, vol. 3, 1998, pp. 2645-2658.
13. Yang J.M., Chin K.V., Hait W.N. Cancer Res. 56:1996;3490-3494.
14. Rennecke J., Rehberger P.A., Furstenberger G., Johannes F.J., Stohr M., Marks F., Richter K.H. Int. J. Cancer. 80:1999;98-103.
15. Paolucci L., Rozengurt E. Cancer Res. 59:1999;572-577.
16. Rozengurt E. Curr. Opin. Oncol. 11:1999;116-122.
17. Vertommen D., Rider M., Ni Y., Waelkens E., Merlevede W., Vandenheede J.R., Van Lint J. J. Biol. Chem. 275:2000;19567-19576.
18. Prestle J., Pfizenmaier K., Brenner J., Johannes F.J. J. Cell Biol. 134:1996;1401-1410.
19. Eisenberg R. Foreman J.C. Textbook of Receptor Pharmocology. 1996;227-237 CRC Press, Boca Raton.
20. Cabell C.H., Verghese G.M., Rankl N.B., Burns D.J., Blackshear P.J. Proc. Assoc. Am. Physicians. 108:1996;37-46.
21. Hausser A., Storz P., Link G., Stoll H., Liu Y.C., Altman A., Pfizenmaier K., Johannes F.J. J. Biol. Chem. 274:1999;9258-9264.
22. Johannes F.J., Horn J., Link G., Haas E., Siemienski K., Wajant H., Pfizenmaier K. Eur. J. Biochem. 257:1998;47-54.
23. Wu D., Terrian D.M. J. Biol. Chem. 277:2002;40449-40455.
24. Martelli A.M., Sang N., Borgatti P., Capitani S., Neri L.M. J. Cell. Biochem. 74:1999;499-521.
25. Newton A.C. J. Biol. Chem. 270:1995;28495-28498.
26. Arai Y., Yoshiki T., Yoshida O. Journal of Urology. 144:1990;1415-1419.
27. Watanabe S., Nakayama N., Yokota T., Arai K., Miyajima A. Curr. Opin. Biotechnol. 2:1991;227-237.
28. Andrews P.E., Young C.Y., Montgomery B.T., Tindall D.J. Cancer Res. 52:1992;1525-1529.
29. Gioeli D., Ficarro S.B., Kwiek J.J., Aaronson D., Hancock M., Catling A.D., White F.M., Christian R.E., Settlage R.E., Shabanowitz J., Hunt D.F., Weber M.J. J. Biol. Chem. 15:2002;15.
30. de Ruiter P.E., Teuwen R., Trapman J., Dijkema R., Brinkmann A.O. Mol. Cell. Endocrinol. 110:1995;R1-R6.
31. Beck C.A., Weigel N.L., Edwards D.P. Mol. Endocrinol. 6:1992;607-620.